A down regulated oncogenic protein HER2 and HER3 were observed in a HER2+ cell line with a reduction in the wild type epidermal growth factor receptor (EGFR or HER1) in a triple negative breast cancer cell line [132]. This evidence concerns the gene EGFR and triple-negative breast carcinoma.